Pharmacokinetics, safety, and immunogenicity of HLX03, an adalimumab biosimilar, compared with reference biologic in healthy Chinese male volunteers: Results of a randomized, double‐blind, parallel‐controlled, phase 1 study

Abstract The primary objective of this randomized, double‐blind, parallel‐controlled study (from December 2016 to October 2018) was to evaluate pharmacokinetic (PK) equivalence of adalimumab biosimilar HLX03 and reference adalimumab in healthy volunteers, and to assess safety, and immunogenicity of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hong Zhang (Autore), Min Wu (Autore), Jixuan Sun (Autore), Xiaoxue Zhu (Autore), Cuiyun Li (Autore), Yanhua Ding (Autore), Xiaodi Zhang (Autore), Katherine Chai (Autore), Xiaojiao Li (Autore)
Natura: Libro
Pubblicazione: Wiley, 2021-04-01T00:00:00Z.
Soggetti:
Accesso online:Connect to this object online.
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Accesso online

Connect to this object online.

3rd Floor Main Library

Dettagli sul posseduto da 3rd Floor Main Library
Collocazione: A1234.567
Copia 1 Disponibile